GLUCOTRACK INC (GCTK:NASDAQ)
$0.7791 0.1145 (17.2284%)
Analysed GLUCOTRACK INC (GCTK:NASDAQ) News Sources
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
30-03-2026
yahoo.com
Glucotrack to File for FDA Exemption Based on 2025 Milestones
28-03-2026
yahoo.com
BC-Most Active Stocks
27-03-2026
yahoo.com
Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones
27-03-2026
yahoo.com
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit
10-03-2026
yahoo.com
Glucotrack Announces 3 New Patents to Monitor Blood Glucose
29-01-2026
yahoo.com
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
29-01-2026
yahoo.com
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
30-12-2025
yahoo.com
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights
13-11-2025
yahoo.com
Glucotrack, Inc. Encourages Shareholders to Vote
03-11-2025
yahoo.com
What is the current price of GLUCOTRACK INC (GCTK:NASDAQ)?
The current price of GLUCOTRACK INC (GCTK:NASDAQ) is $0.7791.
GLUCOTRACK INC (GCTK:NASDAQ) absolute price change since previous trading day?
The absolute price change of GLUCOTRACK INC (GCTK:NASDAQ) since the previous trading day is $0.1145.
GLUCOTRACK INC (GCTK:NASDAQ) percentage price change since previous trading day?
The percentage price change of GLUCOTRACK INC (GCTK:NASDAQ) since the previous trading day is 17.2284%.
What is the most recent average sentiment score for GLUCOTRACK INC (GCTK:NASDAQ)?
The most recent average sentiment score for GLUCOTRACK INC (GCTK:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for GLUCOTRACK INC (GCTK:NASDAQ)?
The most recent sentiment for GLUCOTRACK INC (GCTK:NASDAQ) is .
SEC-8K** Filing Available For GLUCOTRACK INC (GCTK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.